NL-OMON52235已完成不适用
Effects of a physical therapy protocol for patients treated for acetabular fractures - PACE
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 8
研究概览
简要总结
Trial ended prematurely
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •- Patients with a fracture of the acetabulum which will be surgically treated,
- •age 16 or older with a fully grown skeleton*
- •- Able to fill in online questionnaires in Dutch
- •- Able to give written informed consent
- •*When bone growth is complete, the epiphyseal cartilage is replaced with bone,
- •which joints it to the diaphysis. This can be checked with X-rays and CT. Both
- •examinations are part of usual care.
排除标准
- •- Mentally not fit to complete the questionnaire
- •- Not able to perform activities of daily living independently and without
- •mobility aids before the accident
- •- Other injury of the spine, upper or lower extremites that affect mobilization
- •- No use of physical therapy after discharge
- •- Not treated according to the standard rehabilitation protocol (Appendix A)
- •- Illiteracy
研究者
相似试验
已完成
不适用
A preoperative program to promote peri- and postoperative health in patients undergoing thoracic aortic surgery: a randomized controlled trial.thoracic aortic disease100122211000318410002363thoracic aortic aneurysmNL-OMON50977Radboud Universitair Medisch Centrum3
已完成
不适用
A prospective, multicenter clinical study to evaluate the safety profile of the FlexiSurge Adhesion Barrier for the prevention of intra-abdominal adhesion formation after laparotomyvorming van adhesies na buikchirurgieadhesion formationpostoperative adhesionsNL-OMON40303Medisse BV5
已完成
不适用
A prospective clinical follow up study with a New Press-fit Cup with initial RSA analysis (NPC).worn hip10023213OsteoarthritisNL-OMON46964Stichting SCORE28
已完成
不适用
First in Human Study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of PPSGG (PN-1007) in anti-MAG neuropathy patients.anti-MAG neuropathyauto-immune10012303NL-OMON49059Polyneuron Pharmaceuticals AG9
已完成
不适用
A Phase 1 First-in-human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 330 Administered as Continuous Intravenous Infusion in Subjects With Myeloid Malignanciesbeenmergstoornis: MDS (myelodysplastisch syndroom/myelodysplasie)cancer of the blood10024324Acute myeloid leukemiamyelodysplastic SyndromeNL-OMON55859Amgen10
